| scholarly article | Q13442814 |
| P50 | author | Charles A. Dinarello | Q834442 |
| Pascale Paul | Q56909742 | ||
| Daniela Novick | Q77912071 | ||
| P2093 | author name string | Menachem Rubinstein | |
| Nicolas Schleinitz | |||
| Pascale Paul | |||
| Catherine Farnarier | |||
| Gilles Kaplanski | |||
| Valérie Marin | |||
| Stéphane Robitail | |||
| Véronique Veit | |||
| Karin Mazodier | |||
| Jean-Robert Harlé | |||
| P2860 | cites work | Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response | Q22008772 |
| Interleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosis | Q28591879 | ||
| Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome | Q29620423 | ||
| IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells | Q30304035 | ||
| Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review | Q33357155 | ||
| Perforin gene defects in familial hemophagocytic lymphohistiocytosis. | Q33882431 | ||
| A proinflammatory role for IL-18 in rheumatoid arthritis | Q33902122 | ||
| Interleukin-18 regulates both Th1 and Th2 responses | Q34178165 | ||
| The role of cytotoxicity in lymphocyte homeostasis. | Q34360492 | ||
| Interleukin-18 in hemophagocytic lymphohistiocytosis | Q34431462 | ||
| Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities? | Q35213886 | ||
| Defective CTLA-4 cycling pathway in Chediak-Higashi syndrome: a possible mechanism for deregulation of T lymphocyte activation | Q35559258 | ||
| Pathogenesis of hemophagocytic syndrome (HPS). | Q35683336 | ||
| Gene expression, synthesis, and secretion of interleukin 18 and interleukin 1beta are differentially regulated in human blood mononuclear cells and mouse spleen cells | Q37179132 | ||
| Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells | Q37378111 | ||
| IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor. | Q38328380 | ||
| Virus-associated hemophagocytic syndromeA benign histiocytic proliferation distinct from malignant histiocytosis | Q40251317 | ||
| An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder | Q40536555 | ||
| Oversecretion of IL-18 in haemophagocytic lymphohistiocytosis: a novel marker of disease activity | Q40634625 | ||
| Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome | Q40663505 | ||
| Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia | Q40734859 | ||
| Hypercytokinemia in familial hemophagocytic lymphohistiocytosis | Q40741786 | ||
| Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease | Q40819082 | ||
| Bacteria-associated hemophagocytic syndrome | Q40822509 | ||
| The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells | Q41116878 | ||
| Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment | Q41581320 | ||
| Familial hemophagocytic lymphohistiocytosis. Primary hemophagocytic lymphohistiocytosis | Q41751139 | ||
| Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis | Q41751145 | ||
| A novel role for interleukin-18 in human natural killer cell death: high serum levels and low natural killer cell numbers in patients with systemic autoimmune diseases | Q43584281 | ||
| A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18. | Q43702638 | ||
| Increased interleukin-18 expression in bone marrow of a patient with systemic juvenile idiopathic arthritis and unrecognized macrophage-activation syndrome | Q47368371 | ||
| Neutralizing antibodies to IFN-gamma-inducing factor prevent experimental autoimmune encephalomyelitis | Q48339467 | ||
| Macrophage activation syndrome. | Q53961099 | ||
| Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndromes. | Q55242245 | ||
| Calculation of lytic units for the expression of cell-mediated cytotoxicity | Q67744337 | ||
| Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society | Q68192027 | ||
| Impaired natural killer activity in lymphohistiocytosis syndrome | Q70333237 | ||
| Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis | Q73374152 | ||
| Adult onset Still's disease associated hemophagocytosis | Q73601289 | ||
| Serum IL-18 levels in patients with various hematological disorders | Q73859346 | ||
| IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family | Q77807763 | ||
| Proposal for a new set of classification criteria for adult-onset still disease | Q78069999 | ||
| Hemophagocytic lymphohistiocytosis is associated with deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer-cell-induced apoptosis | Q78290400 | ||
| Highly elevated serum levels of interleukin-18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease: comment on the article by Kawashima et al | Q78301243 | ||
| Histiocyte disorders | Q80120439 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 3483-3489 | |
| P577 | publication date | 2005-07-14 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome | |
| P478 | volume | 106 |
| Q33381950 | A Griscelli syndrome type 2 murine model of hemophagocytic lymphohistiocytosis (HLH). |
| Q37869439 | A clinical perspective of IL-1β as the gatekeeper of inflammation |
| Q40042168 | A novel Pyrin-Associated Autoinflammation with Neutrophilic Dermatosis mutation further defines 14-3-3 binding of pyrin and distinction to Familial Mediterranean Fever. |
| Q42358577 | Acquired hemophagocytic syndrome: comment to the case report. |
| Q38167486 | Adult haemophagocytic syndrome |
| Q38637780 | Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? |
| Q92914675 | An IL-18-centered inflammatory network as a biomarker for cerebral white matter injury |
| Q34254955 | An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome |
| Q59136398 | Anakinra Therapy for Non-cancer Inflammatory Diseases |
| Q33872843 | Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age |
| Q61764173 | Atteinte hépatique au cours du syndrome d’activation macrophagique |
| Q33846399 | Clinical analysis of 42 cases of EBV-positive mature T/NK-cell neoplasms |
| Q49362091 | Clinical characteristics, therapy response, and outcome of 51 adult patients with hematological malignancy-associated hemophagocytic lymphohistiocytosis: a single institution experience. |
| Q36369924 | Clinical utility of soluble interleukin-2 receptor in hemophagocytic syndromes: a systematic scoping review. |
| Q93095137 | Current perspectives on the interleukin-1 family as targets for inflammatory disease |
| Q55109011 | Diagnostic and management of life-threatening Adult-Onset Still Disease: a French nationwide multicenter study and systematic literature review. |
| Q37259317 | Divergence of IL-1, IL-18, and cell death in NLRP3 inflammasomopathies |
| Q36281530 | Elevated levels of circulating IL-18BP and perturbed regulation of IL-18 in schizophrenia |
| Q51520537 | Elevated serum levels of free interleukin-18 in adult-onset Still's disease. |
| Q33735958 | Expression of IL-18, IL-18 binding protein, and IL-18 receptor by normal and cancerous human ovarian tissues: possible implication of IL-18 in the pathogenesis of ovarian carcinoma |
| Q33523812 | Failure of interferon gamma to induce the anti-inflammatory interleukin 18 binding protein in familial hemophagocytosis |
| Q35575280 | Favorable in vitro effects of combined IL-12 and IL-18 treatment on NK cell cytotoxicity and CD25 receptor expression in metastatic melanoma patients |
| Q38528624 | From bench to bedside and back again: translational research in autoinflammation |
| Q84874194 | Gamma-delta T-cell lymphomas |
| Q40343423 | Hemophagocytic Syndrome Associated with Hodgkin's Lymphoma First Presenting as Fever and Pancytopenia |
| Q26745468 | Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: A systematic scoping review |
| Q60956230 | IL-13 Contributes to Drug Resistance of NK/T-Cell Lymphoma Cells by Regulating ABCC4 |
| Q37363758 | IL-18 binding protein-expressing mesenchymal stem cells improve myocardial protection after ischemia or infarction |
| Q54305511 | IL-18 serum concentration is markedly elevated in acute EBV infection and can serve as a marker for disease severity. |
| Q37702138 | IL-1: discoveries, controversies and future directions |
| Q28072571 | IL-1β/IL-6/CRP and IL-18/ferritin: Distinct Inflammatory Programs in Infections |
| Q40133010 | IP-10/CXCL10 and MIG/CXCL9 as novel markers for the diagnosis of lymphoma-associated hemophagocytic syndrome |
| Q39650148 | Immunomodulatory IL-18 binding protein is produced by prostate cancer cells and its levels in urine and serum correlate with tumor status. |
| Q37377709 | Increased cytokine production in interleukin-18 receptor alpha-deficient cells is associated with dysregulation of suppressors of cytokine signaling |
| Q88588824 | Indeed, IL-18 is more than an inducer of IFN-γ |
| Q57965153 | Inherited defects causing hemophagocytic lymphohistiocytic syndrome |
| Q37763991 | Inherited defects in lymphocyte cytotoxic activity |
| Q92153992 | Inhibition of the IL-18 Receptor Signaling Pathway Ameliorates Disease in a Murine Model of Rheumatoid Arthritis |
| Q94562624 | Intensive Care Society State of the Art 2018 Abstracts |
| Q37735696 | Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial |
| Q37220336 | Interleukin-18 and IL-18 binding protein |
| Q92618838 | Interleukin-18 binding protein attenuates renal injury of adriamycin-induced mouse nephropathy |
| Q48258109 | Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome |
| Q64275741 | Interleukin-18 in Health and Disease |
| Q42986598 | Interleukin-18 is a key mediator in dermatomyositis: potential contribution to development of interstitial lung disease |
| Q28118491 | Interleukin-18/WNT1-inducible signaling pathway protein-1 signaling mediates human saphenous vein smooth muscle cell proliferation |
| Q47285927 | Interleukin-18: Biological properties and role in disease pathogenesis |
| Q33412732 | Life-threatening complications of adult-onset Still's disease |
| Q47271595 | Lipopolysaccharide-Induced Acute Kidney Injury Is Dependent on an IL-18 Receptor Signaling Pathway |
| Q38234358 | Lymphoma presenting as secondary HLH: a review with a tale of two cases |
| Q38224085 | Macrophage activation syndrome and cytokine-directed therapies |
| Q38408014 | Macrophage activation syndrome in the course of monogenic autoinflammatory disorders. |
| Q38786756 | Macrophage activation syndrome in the era of biologic therapy. |
| Q40077192 | Macrophage activation syndrome triggered by coeliac disease: a unique case report. |
| Q41704840 | Macrophage activation-like syndrome: an immunological entity associated with rapid progression to death in sepsis |
| Q42546120 | Membrane interleukin-18 revisits membrane IL-1α in T-helper type 1 responses |
| Q34541173 | NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndrome |
| Q37143139 | Natural killer cell-directed therapies: moving from unexpected results to successful strategies |
| Q37805560 | Natural killer cells in human autoimmune diseases |
| Q36042041 | Neutralization of IFNgamma defeats haemophagocytosis in LCMV-infected perforin- and Rab27a-deficient mice |
| Q47644899 | OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation. |
| Q47285878 | Overview of the IL-1 family in innate inflammation and acquired immunity |
| Q34042413 | Pathogenesis of adult-onset Still's disease: new insights from the juvenile counterpart. |
| Q38267068 | Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies |
| Q34269827 | Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions |
| Q39865381 | Potential role of interleukin-18 in the immunopathogenesis of AIDS: involvement in fratricidal killing of NK cells |
| Q42265715 | Protection from inflammatory organ damage in a murine model of hemophagocytic lymphohistiocytosis using treatment with IL-18 binding protein |
| Q41029387 | Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab |
| Q39144075 | Review: Cytokine Storm Syndrome: Looking Toward the Precision Medicine Era. |
| Q47103893 | Role of IL-18 in atopic asthma is determined by balance of IL-18/IL-18BP/IL-18R. |
| Q37056441 | Role of IL-18 in second-hand smoke-induced emphysema |
| Q38223099 | Secondary hemophagocytic syndrome: the importance of clinical suspicion |
| Q43459603 | Serum HO-1 is useful to make differential diagnosis of secondary hemophagocytic syndrome from other similar hematological conditions |
| Q48105627 | Suppression of inflammation and acquired immunity by IL-37. |
| Q90084199 | The IL-1 family of cytokines and receptors in rheumatic diseases |
| Q90029250 | The rheumatology/hematology interface: CAPS and MAS diagnosis and management |
| Q37883097 | The role of natural killer cells in sepsis |
| Q38648790 | Therapeutic Potential of Interferon-γ and Its Antagonists in Autoinflammation: Lessons from Murine Models of Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome |
| Q36816872 | Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases |
| Q36514429 | Tuberculosis-associated haemophagocytic syndrome. |
| Q33606120 | Tuberculosis-associated hemophagocytic lymphohistiocytosis with initial presentation of fever of unknown origin in a general hospital: An analysis of 8 clinical cases |
| Q64043858 | [Hemophagocytic Lymphohistiocytosis] |
Search more.